OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer

Core Viewpoint - OptimizeRx Corp. has appointed Steve Silvestro as the new Chief Executive Officer, effective March 10, 2025, to lead the company into its next phase of growth and transformation [1][3]. Company Leadership - Steve Silvestro has over 20 years of experience in health technology and services, having joined OptimizeRx in 2019 as Chief Commercial Officer and later serving as President and interim CEO [2][4]. - The Board of Directors conducted a thorough search for the new CEO, resulting in a unanimous decision to appoint Silvestro, who has been pivotal in enhancing the company's brand relevance and capabilities [3]. Strategic Focus - Silvestro aims to differentiate OptimizeRx through technology and strategic partnerships, emphasizing operational excellence and customer satisfaction [3]. - The company has completed a strategic review of its business processes and is focused on increasing recurring revenue and becoming a "Rule of 40" company, which refers to a combined growth and profit margin of 40% [3]. Company Overview - OptimizeRx is a leading healthcare technology company that connects life science brands with patients and healthcare providers through innovative AI-driven tools [5][6]. - The company is headquartered in Waltham, Massachusetts, and partners with major pharmaceutical and life sciences companies to improve healthcare outcomes [6].